1[1]Siemers ER.Multiple system atrophy[J].Med Clin Am,1 999,83(3):381-392.
2[2]Sakakibara R.Urinary dysfunction and orthostatic hypotension in multiple sy stem atrophy:which is the more common and earlier manifestation?[J].J Neurol Neurosurg Psychiatry,2000,68(1):65-69.
3[3]DeArmond SJ,Dickson DW,De Armond B.Degenerative diseases of the central ner vous system[A].Davis RL,Robertson DM.Textbook of Neuropathology[M].3rd ed. Baltimore:Williams and Wilkins,1997.1063-1178.
4[4]Gilman S,Low DA,Quinn N,et al.Consensus statemnt on the diagnosis of multi ple system atrophy[J].J Neurol Sci,1999,163(1):4-5.
5[5]Wenning GK,Ben-Shlomo Y,Magalhaes M,et al.Clinicopathological study of 35 cases of multiple system atrophy[J].J Neurol Neurosurg Psychiatry,1995,58(2): 16-166.
7[7]Hashimoto M,Masliah E.Alpha-synuclein in Lewy body disease and Alzheimer s disease[J].Brain Pathol,1999,9(6):707-720.
8[8]Goedert M.Filamentous nerve cell inclusions in neurodegenerative diseases:t auopathies and alpha-synucleinopathies[J].Philos Trans R Soc Lond(Biol),1999 ,354(11):1101-1118.
9[9]Gai WP,Power JH,Blumbergs PC,et al.Alpha-synuclein immunoisolation of glia l inclusions from multiple system atrophy brain tissue reveals multiprotein comp onents[J].J Neurochem,1999,73(12):2093-2100.
10[10]Takeda A.C-terminal alpha-synuclein immunoreactivity in struct ures other than Lewy body in neurodegenerative disorders[J].Acta Neuropathol ,2000,99(3):296-304.
